Back to Gene
MED12 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

MED12 gene

The MED12 gene provides instructions for making a protein that is a critical subunit of the Mediator complex, which regulates gene activity and is essential for early development.

Normal Function

The MED12 gene provides instructions for making a protein that forms one part (subunit) of a protein complex called Mediator. This complex is a large group of proteins that work together to regulate gene activity. Mediator connects transcription factors, which are proteins that influence whether genes are turned off or on, with an enzyme called RNA polymerase II. Once transcription factors are attached, RNA polymerase II can start the process of building proteins.

As part of the Mediator complex, the MED12 protein is involved in many aspects of early development, including the development of nerve cells (neurons) in the brain. The MED12 protein is part of several chemical signaling pathways. These pathways help direct a broad range of cellular activities, such as cell growth, cell movement (migration), and the process by which cells mature to carry out specific functions (differentiation).

Health Conditions Related to Genetic Changes

FG syndrome

Pathogenic variants in the MED12 gene can cause FG syndrome type 1, also known as Opitz-Kaveggia syndrome. This condition typically affects men and boys and is characterized by:

  • Intellectual disabilities
  • Weak muscle tone (hypotonia)
  • Broad and flat thumbs
  • Abnormalities of the tissue that connects the left and right halves of the brain (the corpus callosum)
  • Obstruction of the anal opening (imperforate anus)

Two specific pathogenic variants (Arg961Trp and Gly958Glu) alter the structure of the MED12 protein, likely disrupting its ability to regulate gene activity during development.

Lujan syndrome

Pathogenic variants in the MED12 gene can cause Lujan syndrome, a disorder typically affecting men and boys. It is characterized by intellectual disabilities and distinctive physical features, including:

  • A tall, thin body
  • A long and narrow face
  • Long fingers and toes with an unusually large range of movement at the joints (hyperextensibility)

Ohdo syndrome, Maat-Kievit-Brunner type

Pathogenic variants in the MED12 gene can cause the Maat-Kievit-Brunner type of Ohdo syndrome. This rare condition is characterized by intellectual disabilities and distinctive facial features. While it typically affects men and boys, it can sometimes affect girls and women.

Prostate cancer

MedlinePlus Genetics provides information about Prostate cancer.

Other disorders

Pathogenic variants in the MED12 gene are also associated with other conditions:

  • Hardikar syndrome: Characterized by cleft lip (with or without cleft palate), heart problems, gastrointestinal abnormalities, and pigmentary retinopathy, which may cause vision loss. Unlike other MED12-related disorders, this condition affects mostly girls and women.
  • Nonspecific intellectual disability: A condition affecting both men and women that features intellectual disabilities with symptoms that overlap with other MED12-related disorders but do not meet their specific diagnostic criteria.
  • Cancerous and noncancerous growths: Somatic variants (acquired during a person's lifetime) in the MED12 gene have been found in various cancers, including prostate and gastrointestinal cancers, as well as noncancerous growths such as uterine leiomyomas (uterine fibroids). These variants likely disrupt normal cell signaling and growth regulation.

Frequently Asked Questions

FG syndrome type 1 is an X-linked condition caused by mutations in the MED12 gene, which is located on the X chromosome. Males have only one X chromosome, so a single mutation is sufficient to cause the condition, whereas females have two X chromosomes and may be carriers or have milder symptoms. Key physical features include broad and flat thumbs, intellectual disability, low muscle tone (hypotonia), and abnormalities in the corpus callosum, the tissue connecting the brain's hemispheres. How does a mutation in the MED12 gene disrupt normal brain development?::The MED12 protein is a critical part of the Mediator complex, which regulates gene activity by connecting transcription factors to RNA polymerase II. Mutations in MED12 disrupt this regulatory function, particularly during early development when nerve cells are forming. This interference affects signaling pathways that control cell growth, migration, and differentiation, leading to structural brain abnormalities such as corpus callosum issues and functional deficits like intellectual disability. Can females be affected by MED12 mutations, and if so, how does the presentation differ?::Females can be affected by MED12 mutations, but the presentation is often milder or more variable than in males due to X-inactivation, where one X chromosome is randomly silenced in each cell. Some females may have mild intellectual disabilities, learning difficulties, or subtle physical features, while others may be asymptomatic carriers. The severity depends on which X chromosome is active in key tissues during development. What diagnostic steps are typically involved in confirming a MED12-related disorder?::Diagnosis usually begins with a clinical evaluation for characteristic features such as broad thumbs, hypotonia, and developmental delays. Genetic testing is then performed to identify pathogenic variants in the MED12 gene, such as the specific Arg961Trp or Gly958Glu mutations. Brain imaging, such as MRI, may also be used to detect structural abnormalities like corpus callosum defects to support the clinical diagnosis.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA